CJC-1295 DAC With Ipamorelin Dosage: What Research and User Reports Show

The most commonly referenced CJC-1295 DAC with ipamorelin dosage is 1 to 2 mg of CJC-1295 DAC per week paired with 100 to 300 mcg of ipamorelin once or twice daily. The two peptides are stacked because they drive growth hormone release through different receptors, and CJC-1295 DAC's half-life of roughly 6 to 8 days supports weekly dosing while ipamorelin is given daily. Neither peptide is FDA-approved for human use in the United States, so the numbers below come from research literature and community-reported protocols rather than approved clinical guidance.

How CJC-1295 DAC and Ipamorelin Work Together

CJC-1295 DAC is a growth hormone-releasing hormone (GHRH) analog. It binds GHRH receptors in the pituitary, and a drug affinity complex (DAC) side chain lets it attach to albumin in the bloodstream, which is what extends its activity far beyond the version without DAC.

Ipamorelin is a growth hormone secretagogue that acts on the ghrelin receptor instead. In the studies that have examined it, ipamorelin has looked relatively selective, meaning it stimulates GH release without strongly raising cortisol or prolactin.

People who compare cjc-1295 with dac vs ipamorelin usually land on the same conclusion: they are complements, not competitors. One provides a long, steady signal, and the other creates short pulses.

Typical CJC-1295 DAC With Ipamorelin Dosage

Reported ranges vary widely between sources, and no official dosing standard exists. The table below reflects the numbers most often repeated in research discussions and community logs.

Compound	Common reported dose	Frequency	Why
CJC-1295 DAC	1–2 mg	Once weekly, or 0.5–1 mg twice weekly	Half-life of roughly 6–8 days
Ipamorelin	100–300 mcg	1–3 times per day	Half-life of about 2 hours
CJC-1295 (no DAC) plus ipamorelin blend	Depends on vial ratio	1–3 times per day	Short-acting in both directions

When someone searches for cjc-1295 with dac ipamorelin dosage per day, the key point is that the DAC version is not a daily peptide. Its weekly schedule is the entire reason it is dosed differently from the no-DAC form.

Pre-mixed vials labeled as cjc-1295 without dac 5mg ipamorelin 5mg are a separate product category. Those blends are short-acting and are typically dosed one to three times daily, so a weekly DAC schedule does not transfer to them.

Starting Low and Titrating

Most experienced users begin at the low end of the range, around 1 mg of CJC-1295 DAC weekly with 100 mcg of ipamorelin per dose, and adjust only after several weeks. This makes it easier to separate a genuine response from a side effect.

Timing and Injection Practicalities

Ipamorelin is almost always injected before bed, when natural growth hormone release peaks during deep sleep. Some protocols add a second or third dose in the morning or after training.

• Inject on an empty stomach, ideally at least two hours after the last meal.
• Wait 20 to 30 minutes before eating to avoid blunting the GH pulse.
• Rotate injection sites to reduce irritation and lipohypertrophy.
• Keep the time of day consistent, because the pituitary responds to rhythm as much as to dose.

Because CJC-1295 DAC is dosed weekly, its exact injection time matters far less than consistency from week to week. Many people pair it with the same evening ipamorelin dose to keep the routine simple.

Reconstitution and Storage

Reconstitution is where a lot of dosing mistakes begin. Instructions for cjc 1295 dac reconstitution generally call for 1 to 2 mL of bacteriostatic water per vial, and the math matters: a 2 mg vial mixed with 2 mL yields 1,000 mcg per mL, so a 1 mg dose equals a full milliliter.

• Swirl gently, never shake, until the powder fully dissolves.
• Store reconstituted vials in the refrigerator at 2 to 8 °C.
• Protect the vial from light and avoid repeated temperature swings.
• Label each vial with the concentration and the date of mixing.

Lyophilized powder that has not been mixed can be kept frozen or refrigerated for much longer, but once reconstituted, most sources suggest using it within a few weeks. A 1,000 mcg/mL concentration also means small dosing errors translate into large dose differences, so a 0.5 mL or 1 mL insulin syringe with clear markings is worth the extra cost.

Cycle Length and What to Expect

Community-reported cjc 1295 dac cycle length usually runs 8 to 12 weeks, with some users extending to six months. Because the DAC form accumulates in the bloodstream over the first few weeks, results tend to be described as gradual rather than immediate.

Expectations should stay modest. Many cjc 1295 with dac before and after accounts mention better sleep quality, faster recovery between workouts, and small shifts in body composition across two to three months. Those are anecdotal reports, not outcomes from controlled trials.

Tracking IGF-1 through bloodwork is the most common way people try to measure whether the stack is doing anything at all. IGF-1 also happens to be the marker most likely to drift outside the normal range with prolonged use, which is one reason periodic labs and medical supervision come up so often in these discussions.

Safety, Side Effects, and Legal Status

CJC-1295 DAC and ipamorelin are not FDA-approved for human use in the United States. They are sold as research chemicals, which means purity, sterility, and actual peptide content are not verified by any regulator.

Commonly reported side effects include injection site irritation, water retention, fatigue, headaches, and increased appetite. Because both compounds raise growth hormone and IGF-1, there are theoretical concerns about insulin resistance and unwanted tissue growth with long-term use.

Anyone researching these peptides should understand that most claimed benefits, including fat loss, muscle gain, skin quality, and deeper sleep, come from user anecdotes rather than large clinical trials. A licensed healthcare professional is the right person to evaluate whether any of this makes sense for a specific individual.

COMMON QUESTIONS

Frequently Asked Questions

What is the typical CJC-1295 DAC with ipamorelin dosage per day?

CJC-1295 DAC is usually dosed at 1 to 2 mg per week rather than daily, because its half-life is roughly 6 to 8 days. Ipamorelin is the daily component, typically 100 to 300 mcg taken one to three times per day. Splitting the weekly CJC-1295 DAC dose into two smaller injections is also common in community protocols.

How long should a CJC-1295 DAC and ipamorelin cycle last?

Most community protocols run 8 to 12 weeks, and some users extend to six months. Because CJC-1295 DAC builds up in the bloodstream, effects are usually described as gradual over the first four to six weeks. Periodic IGF-1 bloodwork and a check-in with a healthcare professional are common recommendations during that window.

Is CJC-1295 DAC with ipamorelin legal in the US?

CJC-1295 DAC and ipamorelin are not FDA-approved for human use in the United States and are sold strictly as research chemicals. That means the FDA does not verify their purity, sterility, or labeling. Personal possession occupies a legal gray area that varies by state.